Zevra Therapeutics (ZVRA) Minority Interest (2014 - 2015)
Zevra Therapeutics (ZVRA) reported Minority Interest of $28.2 million for Q1 2015, up 16.54% quarter-over-quarter from $24.2 million in Q4 2014.
Zevra Therapeutics (ZVRA) Minority Interest (2014 - 2015) Analysis & Trends
Zevra Therapeutics has reported Minority Interest for 2 years, with the latest figure at $28.2 million in Q1 2015.
- For the quarter ending Q1 2015, Minority Interest changed N/A year-over-year to $28.2 million; the trailing twelve-month figure through Mar 2015 stood at $28.2 million (changed N/A YoY), and the FY2014 full-year result was $24.2 million, changed N/A from the prior year.
- Minority Interest for Q1 2015 stood at $28.2 million, up from $24.2 million in the prior quarter.
- The five-year high for Minority Interest was $28.2 million in Q1 2015, with the low at $24.2 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Zevra Therapeutics | 796.95 Mn | 596.33 Mn | 34.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 28.21 Mn |
| Dec 31, 2014 | 24.21 Mn |